Director Shareholding

GlaxoSmithKline PLC 10 January 2003 Director's Interests I give below details of changes in interests in the Ordinary Share ADRs of GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of the under-mentioned Directors arising from the reinvestment of the dividend paid to Ordinary Share ADR holders on 3 January 2003 through the US Global BuyDirect Plan administered by The Bank of New York: Mr D F McHenry Beneficial interest in 0.2554 of an Ordinary Share ADR purchased at a price of $39.0290 per ADR. Mr J H McArthur Beneficial interest in 33.5474 Ordinary Share ADRs purchased at a price of US$ 39.0290 per ADR. The Directors and the Company were advised of this information on 9 January 2003. S M Bicknell Company Secretary 10 January 2003 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings